Nuveen Asset Management, LLC Imago Bio Sciences, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$15.03 - $35.96 $82,980 - $198,535	-5,521 Reduced 5.36%	97,546 $3.51 Million
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $32,516 - $44,811	-2,298 Reduced 2.18%	103,067 $1.55 Million
Q2 2022 Aug 15, 2022	BUY	$11.81 - $20.92 $617,804 - $1.09 Million	52,312 Added 98.6%	105,365 $1.41 Million
Q1 2022 May 16, 2022	BUY	$16.97 - $25.0 $667,226 - $982,950	39,318 Added 286.26%	53,053 $954,000
Q3 2021 Nov 12, 2021	BUY	$16.0 - $28.84 $219,760 - $396,117	13,735 New	13,735 $275,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.